☰

Melanie S. Brennan, Ph.D. - Publications

Affiliations: 
2014 Neuroscience GMS Boston University, Boston, MA, United States 
Area:
Neuroscience Biology, Molecular Biology, Pharmacy
Tree Info Grants Similar researchers PubMed Report error

2/8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Brennan MS, Patel H, Allaire N, Thai A, Cullen P, Ryan S, Lukashev M, Bista P, Huang R, Rhodes KJ, Scannevin RH. Pharmacodynamics of Dimethyl Fumarate are Tissue-specific and Involve NRF2-dependent and -independent Mechanisms. Antioxidants & Redox Signaling. PMID 26980071 DOI: 10.1089/ars.2015.6622  0.537
2015 Brennan MS, Matos MF, Li B, Hronowski X, Gao B, Juhasz P, Rhodes KJ, Scannevin RH. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. Plos One. 10: e0120254. PMID 25793262 DOI: 10.1371/journal.pone.0120254  0.378
Low-probability matches (unlikely to be authored by this person)
2015 Scannevin RH, Chollate S, Brennan MS, Snodgrass-Belt PA, Peng H, Xu L, Jung MY, Bussiere T, Arastu MF, Talreja T, Xin Z, Dunstan RW, Fahrer D, Rohde E, Dunah AW, et al. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Neuropharmacology. PMID 26690893 DOI: 10.1016/j.neuropharm.2015.12.006  0.281
2016 Grimm J, Bussiere T, Weinreb P, Maier M, Dunstan R, Qian F, Arastu M, Chollate S, Brennan M, Quintero-Monzon O, Scannevin R, Arnold H, Engber T, Rhodes K, Hock C, et al. Human-derived monoclonal antibodies for Alzheimer’s disease and related proteinopathies Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.111  0.214
2016 Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, ... Brennan MS, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 537: 50-6. PMID 27582220 DOI: 10.1038/nature19323  0.202
2021 Wipke BT, Hoepner R, Strassburger-Krogias K, Thomas AM, Gianni D, Szak S, Brennan MS, Pistor M, Gold R, Chan A, Scannevin RH. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33468560 DOI: 10.1212/NXI.0000000000000950  0.147
2017 Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, ... Brennan MS, et al. Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 546: 564. PMID 28640269 DOI: 10.1038/nature22809  0.145
2017 Brennan MS, Matos MF, Richter KE, Li B, Scannevin RH. The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes. Scientific Reports. 7: 42054. PMID 28181536 DOI: 10.1038/Srep42054  0.103
Hide low-probability matches.